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Darier's Disease: A Partially Immunodeficient State 
BRIAN V. JEGASOTHY, M.D., AND JOHN M. HUMENIUK, M.D. 
DiL"ision of Dermatology, Department of Medicine, Dulle University Medical Center and the Veterans Administration M edical Center, 
Durham, North Carolina 
Darier's disease (Keratosis follicularis) a dominantly 
inherited keratinizing disorder of the skin, is associated 
with the d evelopment of severe, progressive viral and 
bacterial skin infections. We investigated the possibility 
that an inadequacy of the immune system might be 
responsible for this tendency. 
Seven of our 8 patients with Darier's disease showed 
complete anergy to common skin test antigens and their 
peripheral blood lymphocytes failed to produce the lym-
phokine, leukocyte inhibitory factor (LIF) in vitro when 
stimulated with the same antigens. One Darier's patient 
and 6 controls showed positivity to at least one skin test 
antigen and produced lymphokine in vitro to the appro-
priate antigen. All patients had normal leukocyte and 
differential counts and normal numbers of circulating T 
and B cells. 
All 8 patients with Darier's disease demonstrated no 
proliferative response to optimal doses of the T cell 
mitogen Con A while showing normal responses to the 
T cell stimulant PHA and the T cell dependent B cell 
stimulant PWM. This previously unreported finding sug-
gests a subtle abnormality of T cells in Darier's and 
might be a marker for these patients. Serum from 2 
patients with Darier's disease did not suppress the in 
vitro immunologic activity oflymphocytes from normals. 
Finally, 13-Cis-retinoic acid in dosages adequate to clear 
their skin disease did not alter the in vivo or in vitro 
immunologic functions in 3 Darier's patients, suggesting 
that the immune dysfunction is not a secondary phenom-
enon. 
Darier-White disease (Keratosis follicularis) [1] is a domi-
nantly inherited disorder of skin keratinization . The disease 
generally becomes clinically apparent during the second and 
third decade of life and is characterized by the development of 
a variable number of greasy, keratotic, noninflammatory skin 
papules in a seborrhoeic distribution. Superficial erosions and 
papules in the oral mucosa, hyperkeratosis of palms and soles 
and typical nail changes may also occur. Histologic examination 
of a primary skin lesion reveals the characteristic findings of 
epidermal acantholysis with lacunae formation and dyskera-
totic cells in the form of corp ronds and grains [2]. Sunlight 
exposure, pregnancy and infections tend to flare these lesions 
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with the development of inflammatory changes in and around 
the papules [1,3,4]. 
Patients with Da.rier's disease have a high propensity to 
develop very severe viral skin infections clinically presenting as 
a potentially catastrophic Kaposis varicelliform eruption [ 4,5]. 
This eruption can occur as a result of infection with H erpes 
simplex virus types I and II [6, 7], vaccinia and Coxsackie A16 
viruses [8,9]. An increased incidence of bacterial skin infections 
in these patients has also been reported [1]. This susceptibility 
to infections may be due to a local disruption of the cutaneous 
barrier fun ction or the result of an underlying defect in general 
host defenses. The occurrence of Kaposis varicelliform eruption 
in some patients without immediately preceding clinical skin 
manifestations of Darier's disease [3] argues very strongly 
against the first supposition. 
Marks, Thor, and Lowe llOJ found no abnormality of humoral 
immunity in 4 patients with Darier's disease in that their 
quantitative immunoglobulins, isohemmagglutinins, comple-
ment levels and numbers of circulating B cells were all normal . 
Further immunofluorescent staining of skin lesions of these 
patients was negative for immunoglobulin or complement dep-
osition. Cell mediated immune functions in these patients how-
ever, was diminished in vivo as judged by decreased skin test 
reactivity to 6 common skin test antigens and reduced migration 
of monocytes as demonstrated by the Rebuck skin window 
technique. Further, the in vitro lymphocyte proliferative re-
sponse to the mitogens phytohemmagglutinin A (PHA) and 
pokeweed mitogen (PWM) and the antigens Streptokinase-
Streptodornase (SKSD) , Candida and purified protein deriva-
tive (PPD) in Da.rier's patients were decreased as was the 
ability of lymphocytes to produce migration inhibitory factor 
(MIF). In contrast, Henry et al [11) in similar studies found no 
abnormality of the in vivo or in vitro cell mediated immune 
response in 3 related and 1 unrelated patient. 
We studied cell mediated immunologic functions in 8 unre-
lated patients with Darier's disease and compared them with 
those of 8 normal healthy control people. We also attempted to 
determine the relationship of the immune function abnormali-
ties we found with a clinical history of severe viral and/ or 
bacterial infections. Finally, we compared the immune function 
studies in patients whose skin disease was significantly im-
proved with 13-Cis retinoic acid before and after treatment. 
MATERIALS AND METHODS 
I. Subjects 
Eight umelated patients with Darier's disease, 4 males and 4 females, 
(ages 27-66-mean 39 yr) were studied. The diagnosis of Darier's 
disease in these patients was established on the basis of chru·acteristic 
clinical and histologic criteria. The patients were questioned closely 
and medical histories checked carefuUy for information regarding pre-
vious cutaneous or sytemic infections. Control subjects investigated 
included 8 healthy normal volunteers, 5 males and 3 females, (ages 26-
63-mean 36 yr) . Three Dru·ier's patients had studies performed on 2 
occasions-once prior to starting the treatment of Darier's disease with 
13-Cis retinoic acid and once while taking an adequate dosage (maxi-
mum dose 4 mg/ kg/ day) of the drug so that they demonstrated >75% 
clinical improvement of their skin disease. 
2. Immunologic studies 
a. Intradermal sliin testing for delayed hypersensitivity: The in vivo 
delayed hypersensitivity response was measured by the assessment of 
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skin test react ivity to 3 common skin test antigens, PPD, and S KS D. 
Uninvolved fl exor skin of t he forearm was inj ected intradermally in 
each of 3 sites with 0.1 ml of PPD (5TU , Parke Davis Company, 
Detroit, Michl. Candida albicans (1 :100, Hollister-Steier, Spokane, 
Washington) or S KS D (100/25, Lederle Laboratories, Pearl River, NY). 
A pa lpable indura tion equal to or greater than 7 mm at 48 hr was 
interpreted as a posit ive reaction. 
b. In t·itro Leuhocyte l nhibitoty Factor (L IF) production: LIF pro-
duction by lymphocytes responding to prote in ant ige n was assessed by 
measuring the inhibition of leukocyte migration in to agarose, using a 
modification of the method of Spitler and Von Mueller [12). Brie fl y, 
heparinized blood from the subj ec ts was allowed to sediment a t 37°C. 
Th e buffy coa t ce lls were drawn off, diluted with phosphate buffered 
saline (PBS) and centrifuged at 250 g for 10 min at room temperature 
in a Sorvall RC5 centrifuge (Dupont Ins truments, Newton, Conn.). Th e 
supernatant was discarded and the pellet of cells washed x 3 in PBS 
and suspended in RPM! 1640 medium with penicillin and streptomycin 
(Gibco, Grand Island, New York) , conta ining 10% horse serum (Gibco) 
2 mM fresh L-Glutamine (Gibco), a t a concentration of 2.2 x 10" cells/ 
mi. Fifty micro litres of cell suspension was incubated for 30 min at 37°C 
with eith er 25 11g/ ml PPD, 50/ 12.5 units SKSD or 5 111. 1:100 Candida 
in small sterile plastic t ubes and then 71111 samples from each incubation 
mixture were inoculated into triplicate wells cut in agarose plates. The 
agarose plates were prepared earlier by layering 6 ml of agarose mixture 
(which is prepared by dissolving 60 gms Indubiose agarose (Accurate 
Scientific and Chemical Corporation, Hicksville, New York) in 6 ml 
water by boiling and adding 0.6 ml horse serum (Gibco), 0.6 ml 10 X 
medium 199 with penicillin and streptomycin (Gibco) and 50 11! 10% 
sodium bicarbonate (G ibco) on t issue culture dishes (Falcon Plast ics, 
Oxnard, California N:3002). Three milimeter diameter holes are cut in 
the agarose after it sets to form the microwells. After addit ion of cells 
with or without an tigen to the microwells t he dishes were covered and 
incubated a t 37°C in a moist atmosphere containing 5% C02 for 18 hr. 
Two diameters of maximum migra tion of ce lls into agarose are 
measured and ave raged for each well. 100% migration is that seen in 
control wells conta ining cells but no ant igen. Percent migration is 
calculated fo r antigen conta ining wells. Less t han 80% migra tion is 
significant and indicative of LIF production [12). 
c. Assay for T and B cell frequencies: T cells were enumerated by a 
standard E rose tting techniq'ue [1 3] where the number of neuraminidase 
treated, fi co ll hypaque purified peripheral mononuclear cells which 
spontaneously rosette wi th sheep red blood cells are counted. Noma-
setting ce lls bearing surface immunoglobulin 0 , G and M (which were 
demonstrated by using commercially ava ilable fluorescein- tagged mon-
ospecific antisera) were identified as B ce lls [1 3). 
d. In vitro lymphocyte proliferative studies: The lymphocyte prolif-
erative response to mitogens was determined according to the techn ique 
of Oppenheim and Rosenstreich (14). Washed buffy coat periphera l 
blood cells from subjects obtained as described above are diluted in an 
equal volume of PBS and layered on Ficoll-Paque (Pharmacia Chemi-
cals, Piscataway, New J ersey) (at a vo lume ratio of 4:3, ce ll suspens ion 
to Ficoll-Paqu e) in a centrifuge tube and spun at· 250 g for 40 min at 
room temperature.· The interphase mononuclear cells were drawn off 
and washed well with PBS. They were then resuspended in RPM! 1640 
with penicillin and streptomycin, 20% horse serum and 2 mM fresh L-
Glu tanimine. 0. 1 ml of cell suspens ion containing 5 X 10'' cells was 
incubated in duplicate wells of a Linbro microwell plate (Linbro Sci-
entific, Hamden, Conn) with either Concanavalin A (Con A) 20 11g/ ml, 
PHA 2 11llml o r PWM 5 11g/ml in a total volume of 0.2 ml at 37°C and 
5% C02 for 72 hr . 1H-Thymidine 6.7 ci/mM (New England Nuclear, 
Boston, Mass) luCi/well was added for the final 24 hr of cul ture. The 
cells were harvested from individual wells using a semiautomatic mul-
tip le well cell harveste r (Otto Hiller Co., Madison, Wisconsin) and TCA 
precipitable ' H counts determined in an Intertechnique Scintillat ion 
counter. · 
S imulation Index 
·'H thymidine incorporation by stimulated 
lymphocytes 
·'H thymidine incorpora tion by unstimulated 
lymphocytes 
An index 3 was considered a positive response because it represents th e 
95o/c confidence limi t of the react ivi ty of lymphocytes from a large 
population of control subjects. 
e. Effect of serum from Darier's patients on normal lymphocyte 
fun ction : Lymphocyte proliferation studies were performed as detailed 
above in normal controls in the presence and absence of serum from 2 
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patients with Darier·s disease. Darier's serum was used at 20% and 40<( 
concentration. R esul ts were compared for evidence of s timulatory or 
inhibitory effect of t he serum. 
RESULTS 
1. Clinical Features of 8 Patients with Darier's Disease 
Eight unrelated patients who were studied had a mean age of 
29 yr (Table I). Four patients had clinically apparent disease 
during childhood while the other 4 developed it in the 3rd 
decade of life. Three patients gave a history of recurrent pyo-
dermas, sometimes beginning on previously normal skin, which 
responded promptly to appropriate systemic antibiotic therapy. 
One patient was treated for recurrent, severe viral upper res-
piratory infections throughout her life and had recently re-
covered from 2 episodes of viral pneumonitis. None of the 
patients had developed Kaposis varicelliform eruptions. 
2. Skin Test Reactivity and LIF Production 
Table II depicts skin test reactivity correlated with LIF pro-
duction in 8 patients with Darier's disease and 8 controls . Seven 
out of 8 patients with Darier's disease were completely anergic 
to skin testing and did not produce any LIF in vitro. One 
Darier's patient showed normal in vivo delayed hypersensitivity 
and corresponding in vitro LIF production to SKSD and Can-
dida. All 8 control subj ects studied showed at least 1 positive 
skin test and in each case corresponding LIF production. N eg-
ative skin tests were associated with the absence of LIF pro-
duction in vitro. Overall reactivity to skin testing in our controls 
was 100% to SKSD, 37.5% to PPD and 50% to Candida. 
3. Lymphocyte Response to Mitogens 
Overall lymphocyte proliferation study data in 8 patients 
with Darier's disease and 6 controls is shown in the Figure. The 
T ABLE I. Clinical features of patients with Dariers disease 
Patient Age Sex Onset of disease Clinical infect ion 
1 ES 36 M Childhood Recurrent pyodermas 
2 SR 27 F 4 yr None 
3 DH 51 M 12 yr None 
4 S P 37 F 20 yr Recurrent pyodermas 
5CW 66 M 30 yr Recurren t pyodermas 
6 ss 34 F 20 yr Recurrent viral URI and 
pneumonitis 
7 WH 38 M 28 yr None 
8 TG '29 F 16 yr None 
TABLE II. Shiniest reactivity and leuhocyte inhibitoty fa ctor (LIF) 
production 
Darier·s disease 1 
2 
3 
4 
5 
6 
7 
8 
Controls 
3 
5 
6 
7 
8 
Streptokinase- Purified protein 
St reptodornase deri va tives 
Sk in LIF" Test 
96.6 
108. 7 
101 
81.7 
89.2 
87.2 
91.0 
+ 69.5 
+ 48.1 
+ 57. 1 
+ 57.4 
+ 73.3 
+ 52.0 
+ 64. 1 
+ 68.8 
+ 49.2 
Skin 
Test 
+ 
+ 
+ 
LIF" 
81.2 
98.4 
100.4 
96.0 
96.3 
96. 1 
87 .5 
89.2 
94 .1 
97 .4 
100.0 
69. 1 
78.2 
104 .1 
44 
99.3 
Candida 
'k in 
Test 
+ 
+ 
+ 
+ 
+ 
LIF" 
89.7 
114.2 
98.6 
88.3 
98.1 
91.4 
84.6 
7i.5 
100.3 
99.2 
102 .8 
100 
47.2 
76.8 
70.3 
66.4 
" E xpressed as "if migration of control, less t han 80% migration signifie 
product ion of LIF. 
Feb. 1981 
only significant finding was a complete lack of response by 
lymphocytes of Darier's patients to optimum concentration (20 
1-Lg/ ml) of the stimulant Con A (stimulation index 1.03) when 
compared with control stimulation index 15.78 (p <0.02). Fw--
ther varying concentrations of Con A (5-40 1-Lg/ rnl) produced 
no s timulation effect. The PHA and PWM response of lympho-
cytes of Da1·ier's patients was not significantly different from 
controls (p > 0.1) in each case. 
4. Enumeration ofT and B Cells 
Total circulating peripheral T cells in each of om patients, 
average (66.2% ± 2.4) did not differ from those of controls 
(68.9% ± 2.2) (p >0.1) (Table III). Similarly B cell numbers 
were also not significantly different in patients versus controls 
(average 15.5% ± 1.2) versus (15.3 ± 1.9) (p > 0.1). 
5. E ffect of Serum from Darier's Patients on Normal 
Lymphocyte Function 
Table IV depicts the effect of serum from 2 patients with 
Darier's disease (who were completely anergic) on the in vitro 
functio n of normal lymphocytes. No stimulatory or inhibitory 
effect was seen on normal lymphocytes as assessed by the 
proliferative function to mitogens in the presence of patients' 
serum. 
6. Studies of Lymphocyte Function Following Treatment of 
Darier's Disease with 13-Cis Retinoic Acid 
Resul ts of in vivo and in vitro lymphocyte functions in 3 
Darier's patients after 8 weeks of treatment with 13-Cis retinoic 
acid (max. dose 4 mg/kg/ day) are shown in Table V. Clinically, 
a greater t han 75% clem·ing of skin lesions was noted at the time 
of study. As seen in the table, no change in skin test reactivity, 
LIF production or lymphocyte response to mitogens was noted 
at the time of clinical improvement of skin disease. 
DISCUSSION 
We studied the in vivo and in vitro cell mediated immune 
functions in 8 patients with Darier 's disease and compared 
them to similar studies in an age and sex matched healthy 
control group. We found a profound decrease in cellulm· im-
munity in 7 of 8 patien ts with Darier's disease as demonstrated 
by cutaneous anergy on skin testing to 3 common antigens, 
SKSD , PPD a nd Candida and a corr esponding Jack of in vitro 
production of the lymphokine LIF by patients' lymphocytes in 
response to the same antigens. Control subj ects on the other 
X 
w 
0 
z 
z 
0 
i= 
<( 
...J 
::J 
::.;; 
i= (f) 
70 
60 
50 
0 Doriers 
t2'l Control 
PHA PWM 
STI MULANTS 
Mitogen responsiveness of lymphocytes. Bars represent standard 
errors of the mean. 
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TABLE III. Peripheral circulating T and B cell frequencies 
T B 
Darier's pts. 1 68 16 
2 65 17 
3 64 14 
4 64 16 
5 66 14 
6 70 16 
7 67 15 
8 66 15 
Average 66.2 ± 2.4" 15.5 ± 1.2" 
Control 1 70 14 
2 66 15 
3 68 18 
4 71 14 
5 69 14 
6 70 17 
Average 68.9 ± 2.2" 15.3 ± 1.9" 
"S.D. P values - T cells , Darier's vs. Control 0.1 B cells, Darier's vs. 
Control 0.1. 
TABLE IV. Effect of serum from Dariers patients on in. vitro 
function of normal lymphocytes 
Test Co ntrol Patient 3 Patient 5 serum 20% se rum 20% 
Con A response (Sl)" 26.49 40.35 41.29 
PHA response (Sl)" 59.46 96.49 78.1 7 
PWM response (Sl)" 12.86 12.98 12.69 
"Stimula tion index-See Materials and Methods. 
TABLE V. Immunologic studies following treatment of Darier 's 
disease patients with 13-Cis retin.oic acid 
Patient I Patient 2 Patient 3 
T est On Off On Off On Off 
Drug Drug Drug Drug Drug Drug 
LIF" 
S KSD 107. 1 96.6 104 .0 101.0 88.7 81.7 
PPD 102.8 81.2 98.3 100.4 94.2 96.0 
Candida 109.2 85.7 102.0 98.6 100.0 88.3 
Mi togen s timula tion 
Con A-(Sl)'' 1.30 1.16 .96 .86 1.03 1. 22 
PHA-(SI) '' 13.33 16.38 5.59 5.46 16.11 36.16 
PWM -(SI)'' 14.95 13.21 14.02 21. 12 21.67 15.24 
" Leukocyte inhibito r factor-expressed as % migration of cont rol. Less 
than 80% signifies LIF production . "Stimulation Index-See Materia ls 
and Methods. 
hand showed positivity to at least one skin test antigen and LIF 
production in. vitro to the appropriate antigen. Positive reaction 
rates of t he skin tests in our control subjects to SKSD, PPD 
and Candida were comparable to the rates of positivity of these 
ant igens seen in a large ra ndomized general population (10). All 
7 pat ients with diminished cellular immune functions had not 
only normal white blood ceil and differential counts, but also 
had ent irely normal numbers of cu·culating peripheral T cells 
indicating that this decrease in cellular immunity is not due to 
a reduction in absolute number ofT cells. One of our patients 
with Darier's disease had entu·ely normal delayed immune 
function as measured by our parameters. This might suggest 
the existence of 2 populations of Darier's patients, a group with 
abnormal cellular immunity and a second one whose immune 
functions a re entu·ely normal. However, many more patients 
need to be studied before definite subgroups can be defined 
since, in our study, only one patient differed from the rest. If 2 
such groups were present, it might also suggest a reason for t he 
discrepant resul ts obtained in previous studies of small numbers 
' of patients (10,11], where the small numbers of patients studied 
might preclude the delineation of one subgroup. 
An un expected and very interesting finding was the complete 
Jack of response of lymphocytes of all 8 patients with Darier's 
disease to optimum concentrations of the T cell mitogen Con 
A, while showing normal stimulatory responses to another T 
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cell mitogen, PHA, and the T dependent B cell stimulant, 
PWM. Since the concentration of lectin has an effect on the 
production of the response [15], we investigated the response of 
lymphocytes of these patients to varying doses of Con A without 
any success in producing stimulation. A similar preferential 
diminution of reactivity of lymphocytes to Con A has been 
identified in other diseases like atopic dermatitis [16], sarcoid-
osis [17], psoriasis [18-21] and aging [20]. Further, like in 
Darier's disease, some of these diseases e.g., atopic dermatitis 
and aging are associated with high incidence of severe viral and 
bacterial infection [16,21]. 
Three hypotheses may be advanced to explain the diminution 
of response to Con A. They are: 
1. A lack of receptors for Con A on lymphocytes, or the 
complete absence of a subpopulation of T cells that normally 
respond to Con A. Previous studies suggesting the absence of 
such a population of Con A responsive cells in patients with 
agammaglobulinema and their normal parents [22] is pertinent 
to this argument. 
2. Normal numbers of receptors for Con A are present but 
they are functionally impotent. Studies demonstrating normal 
binding of Con A to receptors on cortisone-sensitive mouse 
thymocytes which show no proliferative response to Con A 
[23,24] lends credence to this hypothesis, and 
3. The presence of an active suppression phenomenon affect-
ing the Con A response could be postulated. Usually however, 
suppressor effects affecting lectin responses tend to be less 
specific and affect the response to all T cell lectins in an equal 
manner [25]. Suppression affecting only the Con A response 
would therefore be an extraordinary situation. 
We investigated t he possibility that depression of the Con A 
response in patients with Darier's disease is due to active 
immune suppression caused by a circulating suppressor factor. 
Such suppression has been previously postulated in other dis-
eased states associated with a decreased Con A response 
[16,18,19]. Serum from. 2 patients with Darier's patients who 
were totally anergic, however, had no suppressive effect on the 
in vitro response of lymphocytes from a normal individual to 
any of the mitogens tested. Concentrations of serum up to 40% 
had no inhibitory effect suggesting that under our experimental 
condit ions, no circulating suppressor was detected. 
T he clinical importance of this uniql)e finding, i.e., the iso-
lated lack of response to Con A, might lie in its ability to 
represent a distinct genetic marker that might enable identifi-
cation of patients with Darier's disease. Its significance as a 
genetic marker assumes even greater proportions with our 
finding that a normal brother of a patient with Darier's does 
not have this abnormality. However, further careful study must 
be undertaken in a greater number of patients, in the light of 
finding of a normal Con A response in 4 patients with Darier's 
disease by Henry et al [11]. 
Immunologic functions studied in patients who were previ-
ously anergic show no change following treatment of skin dis-
ease with 13-Cis-retinoic acid at doses which caused significant 
improvement of the skin disease. The effect of 13-Cis-retinoic 
acid on in vivo and in vitro immunologic functions have not 
been clearly ·d~fined at the present time and hence the lack pf 
change here should be interpreted with caution. However, the 
alleviation of skin disease without change in the immune func-
tions tested might suggest that the immunologic defect is not 
secondary to the skin disease, but represents a primary dys-
function. 
Finally, we found no definite correlation between the inci-
dence of skin infections and the underlying immunologic ab-
nonnality that we demonstrated. One patient with severe re-
current viral upper respiratory infections and mild Darier's 
disease had abnormal immunologic findings as did 3 patients 
with recurrent pyodermas. However, 3 patients with no history 
of clinical infections also had the same underlying cellular 
immune defect. Our one patient with normal immune functions 
had no history of infections. It should be emphasized this lack 
of correlation between skin infections and immune abnormali-
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ties applies only to those immunologic functions we tested. It is 
entirely possible that there are other immune parameters which 
may show a positive correlation in view of the inability of these 
patients to handle skin infection normally. 
In conclusion, our studies suggest that there exists an under-
lying subtle defect of cell mediated immunity in a dist inct 
subset of patients with Darier 's disease, which appears not to 
be secondary to their skin. The importance of this defect as a 
genetic marker in patients and carriers of the disease needs to 
be further evaluated. There appears to be no definite relation-
ship between certain immune abnormalities we tested and th e 
severe viral and bacterial skin infections that occur in these 
patients. 
The authors acknowledge the help of Wendy Hurwitz who performed 
some init ial studies, Donald Battles for expert technical assistance and 
Marcia Beard who typed the manuscrip t . 
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